ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SI vs MRK // OPERATING MARGIN

Shoulder Innovations Inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: SI 4 — MRK 7
▲ OPERATING MARGIN LEADER: MRK
operating-margins
-55.60%
operating-margins
34.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SI VS. MRK) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SI MRK SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 76.50% 74.80% +1.70 SI /gross-margins <GO>
Return on Invested Capital (ROIC) -16.10% 20.70% -36.80 MRK /roic <GO>
EV/EBITDA & P/E Valuation — 15.3x — TIE /valuation <GO>
Free Cash Flow Yield -8.46% 3.42% -11.88 MRK /fcf-yield <GO>
Operating Margin ACTIVE -55.60% 34.30% -89.90 MRK /operating-margins <GO>
Net Profit Margin -60.00% 28.10% -88.10 MRK /net-margins <GO>
Revenue Growth (YoY) 49.60% 1.30% +48.30 SI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 2.26% -2.26 MRK /dividend-safety <GO>
Altman Z-Score & Debt/Equity 8.73 5.19 +3.54 SI /balance-sheet <GO>
Piotroski F-Score Quality 5/9 7/9 -2.00 MRK /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.1 51.7 +8.40 SI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.92 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 18.4x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $425.5M $361.02B -$360.60B MRK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SI REV MRK REV SI GROSS % MRK GROSS % SI FCF MRK FCF
FY 2025 $47.3M $65.01B 76.5% 74.8% -$36.0M $12.36B
FY 2024 $31.6M $64.17B 77.0% 76.3% -$18.2M $18.10B
FY 2023 — $60.12B — — — $10.30B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SI // BETA —
MRK // BETA 0.92